List of Tables
Table 1. Global Anti-radiation Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-radiation Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-radiation Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-radiation Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-radiation Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-radiation Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-radiation Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-radiation Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-radiation Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-radiation Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-radiation Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-radiation Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-radiation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-radiation Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-radiation Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-radiation Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-radiation Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-radiation Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-radiation Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-radiation Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-radiation Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-radiation Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-radiation Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-radiation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-radiation Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-radiation Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-radiation Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-radiation Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-radiation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-radiation Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-radiation Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-radiation Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-radiation Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-radiation Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-radiation Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-radiation Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-radiation Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-radiation Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-radiation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-radiation Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-radiation Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-radiation Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-radiation Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-radiation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-radiation Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-radiation Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-radiation Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-radiation Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-radiation Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-radiation Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-radiation Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-radiation Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-radiation Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-radiation Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-radiation Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-radiation Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-radiation Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-radiation Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-radiation Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-radiation Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-radiation Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-radiation Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-radiation Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-radiation Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-radiation Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-radiation Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-radiation Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-radiation Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Amgen Anti-radiation Drugs Product
Table 74. Amgen Recent Developments/Updates
Table 75. Anbex Company Information
Table 76. Anbex Description and Business Overview
Table 77. Anbex Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Anbex Anti-radiation Drugs Product
Table 79. Anbex Recent Developments/Updates
Table 80. BTG International Company Information
Table 81. BTG International Description and Business Overview
Table 82. BTG International Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. BTG International Anti-radiation Drugs Product
Table 84. BTG International Recent Developments/Updates
Table 85. Cellphire Company Information
Table 86. Cellphire Description and Business Overview
Table 87. Cellphire Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cellphire Anti-radiation Drugs Product
Table 89. Cellphire Recent Developments/Updates
Table 90. Chrysalis BioTherapeutics Company Information
Table 91. Chrysalis BioTherapeutics Description and Business Overview
Table 92. Chrysalis BioTherapeutics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Chrysalis BioTherapeutics Anti-radiation Drugs Product
Table 94. Chrysalis BioTherapeutics Recent Developments/Updates
Table 95. Darnitsa Company Information
Table 96. Darnitsa Description and Business Overview
Table 97. Darnitsa Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Darnitsa Anti-radiation Drugs Product
Table 99. Darnitsa Recent Developments/Updates
Table 100. Enzychem Lifesciences Company Information
Table 101. Enzychem Lifesciences Description and Business Overview
Table 102. Enzychem Lifesciences Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Enzychem Lifesciences Anti-radiation Drugs Product
Table 104. Enzychem Lifesciences Recent Developments/Updates
Table 105. Humanetics Company Information
Table 106. Humanetics Description and Business Overview
Table 107. Humanetics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Humanetics Anti-radiation Drugs Product
Table 109. Humanetics Recent Developments/Updates
Table 110. Mission Pharmacal Company Information
Table 111. Mission Pharmacal Description and Business Overview
Table 112. Mission Pharmacal Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Mission Pharmacal Anti-radiation Drugs Product
Table 114. Mission Pharmacal Recent Developments/Updates
Table 115. Partner Therapeutics Company Information
Table 116. Partner Therapeutics Description and Business Overview
Table 117. Partner Therapeutics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Partner Therapeutics Anti-radiation Drugs Product
Table 119. Partner Therapeutics Recent Developments/Updates
Table 120. Myelo Therapeutics Company Information
Table 121. Myelo Therapeutics Description and Business Overview
Table 122. Myelo Therapeutics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Myelo Therapeutics Anti-radiation Drugs Product
Table 124. Myelo Therapeutics Recent Developments/Updates
Table 125. Pluri Company Information
Table 126. Pluri Description and Business Overview
Table 127. Pluri Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Pluri Anti-radiation Drugs Product
Table 129. Pluri Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Anti-radiation Drugs Distributors List
Table 133. Anti-radiation Drugs Customers List
Table 134. Anti-radiation Drugs Market Trends
Table 135. Anti-radiation Drugs Market Drivers
Table 136. Anti-radiation Drugs Market Challenges
Table 137. Anti-radiation Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-radiation Drugs
Figure 2. Global Anti-radiation Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-radiation Drugs Market Share by Type: 2024 & 2031
Figure 4. Potassium lodide (KI) Product Picture
Figure 5. Prussian Blue Product Picture
Figure 6. DTPA (Diethylenetriamine Pentaacetate) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-radiation Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Anti-radiation Drugs Market Share by Application: 2024 & 2031
Figure 10. Acute Radiation Syndrome(ARS)
Figure 11. Cancer Treatment
Figure 12. Radiation Exposure
Figure 13. Others
Figure 14. Global Anti-radiation Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti-radiation Drugs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Anti-radiation Drugs Sales (2020-2031) & (K Units)
Figure 17. Global Anti-radiation Drugs Average Price (US$/Unit) & (2020-2031)
Figure 18. Anti-radiation Drugs Report Years Considered
Figure 19. Anti-radiation Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Anti-radiation Drugs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Anti-radiation Drugs Players: Market Share by Revenue in Anti-radiation Drugs in 2024
Figure 22. Anti-radiation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Anti-radiation Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Anti-radiation Drugs Sales Market Share by Country (2020-2031)
Figure 25. North America Anti-radiation Drugs Revenue Market Share by Country (2020-2031)
Figure 26. United States Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Anti-radiation Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Anti-radiation Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Anti-radiation Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Anti-radiation Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Anti-radiation Drugs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Anti-radiation Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Anti-radiation Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Anti-radiation Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Anti-radiation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-radiation Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Anti-radiation Drugs by Type (2020-2031)
Figure 56. Global Anti-radiation Drugs Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Anti-radiation Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Anti-radiation Drugs by Application (2020-2031)
Figure 59. Global Anti-radiation Drugs Price (US$/Unit) by Application (2020-2031)
Figure 60. Anti-radiation Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
